[PCSK9 inhibitors on reimbursable prescription: who is eligible?].
Semb AG, Vesterbekkmo EK, Retterstøl K, Atar D, Solberg EE, Schirmer H, Løchen ML, Kask A, Grimsmo J, Ingul CB, Munkhaugen J.
Semb AG, et al. Among authors: retterstol k.
Tidsskr Nor Laegeforen. 2023 May 29;143(8). doi: 10.4045/tidsskr.23.0191. Print 2023 May 30.
Tidsskr Nor Laegeforen. 2023.
PMID: 37254976
Free article.
Norwegian.
No abstract available.